References
Friedman S: The inhibition of DNA (cytosine-5) methylases by 5-azacytidine. The effect of azacytosine-containing DNA. Mol Pharmacol 19:314–320, 1981
Riggs AD, Jones PA: 5-methlycytosine, gene regulation, and cancer. Adv Canc Res 40:1–29, 1985
Jones PA, Taylor SM: Cellular differentiation, cytidine analogs, and DNA methylation. Cell 20:85–93, 1980
Razin A, Webb C, Szyf M, Yisraeli J, Rosenthal A, NavehMany T, Sciaky-Gallili N, Cedar H: Variations in DNA methylation during mouse cell differentiationin vivo andin vitro. Proc Natl Acad Sci (USA) 81:2275–2279, 1984
Darmon M, Nicolas JF, Lamblin D: 5-azacytidine is able to induce the conversion of teratocarcinoma-derived mesenchymal cells into epithelial cells. EMBO J 3:961–967, 1984
Quagliana JM, O'Bryan RM, Baker L, Gottlieb J, Morrison FS, Eyre JH, Tucker WG, Costanzi J: Phase II study of 5-azacytidine in solid tumors. Canc Treat Rep 61:51–54, 1977
Author information
Authors and Affiliations
Additional information
Other participating institutions include: Mayo Clinic, Rochester, MN (CA 13650); University of Pennsylvania Cancer Center, Philadelphia, PA (CA 15488); University of Wisconsin Comprehensive Cancer Center, Madison, WI (CA 21076), USA
Rights and permissions
About this article
Cite this article
Roth, B.J., Elson, P., Sledge, G.W. et al. 5-Azacytidine (NSC 102816) in refractory germ cell tumors. Invest New Drugs 11, 201–202 (1993). https://doi.org/10.1007/BF00874155
Issue Date:
DOI: https://doi.org/10.1007/BF00874155